Clay-Based Pharmaceutical Formulations and Drug Delivery Systems

This book includes recent advances in the use of clays in the design of medicinal products and medicinal devices. The pharmaceutical applications of nanoclays are far ranging, because of their distinct advantages: they are versatile (possess a wide range of mechanical, chemical and physical properti...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (202 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545151804498
ctrlnum (CKB)5400000000040756
(oapen)https://directory.doabooks.org/handle/20.500.12854/68311
(EXLCZ)995400000000040756
collection bib_alma
record_format marc
spelling Viseras, César edt
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (202 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
This book includes recent advances in the use of clays in the design of medicinal products and medicinal devices. The pharmaceutical applications of nanoclays are far ranging, because of their distinct advantages: they are versatile (possess a wide range of mechanical, chemical and physical properties) and available at reasonable costs. Some special clays (mainly kaolinite, halloysite, montmorillonite, saponite, hectorite, palygorskite and sepiolite), as well as semi-synthetic (organoclays) or synthetic (double layer hydroxides) derivatives, are very useful materials for modulating drug delivery. In the last decade, several actives have been loaded onto nanoclays and similar inorganic excipients to increase solubility, improve stability, reduce toxicity, and enhance bioavailability, with a consequent increase in therapeutic response. Polymer/clay nanocomposites with synergic properties have been developed, showing improved mechanical properties with respect to the pristine polymer matrices and allowing modified release of loaded actives. Moreover, nanoclays have very recently demonstrated positive effects on the proliferation and migration of fibroblasts. The development of clay-based medicinal products and medicinal devices requires experience in the fields of both clay structure and properties and pharmaceutical technology design.
English
Medicine bicssc
hydrochlorothiazide
cyclodextrins
sepiolite
nanoclay
dissolution rate
tablet
electrospinning
chitosan
chondroitin sulfate
scaffolds
montmorillonite
halloysite
fibroblasts proliferation
immune response
glycosaminoglycans
antimicrobial properties
palygorskite
spring water
hydrogel
fibroblast
biocompatibility
wound healing
mesoporous clay
Neusilin
aeroperl
liquisolid technique
glyburide
dissolution improvement
hydrotalcite
ketoprofen
hybrid
photostability
hydrogel film
bioadhesion
heavy metal
hazardous element
element mobility
clay minerals
toxicity
palygorksite
proliferation
Franz cell
bioactive elements
praziquantel
drug
organic solvents
in vitro dissolution tests
cytotoxicity
targeted drug delivery
halloysite nanotube
osteosarcoma
methotrexate
surface modification
3-0365-0186-X
3-0365-0187-8
Viseras, César oth
language English
format eBook
author2 Viseras, César
author_facet Viseras, César
author2_variant c v cv
author2_role Sonstige
title Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
spellingShingle Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
title_full Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
title_fullStr Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
title_full_unstemmed Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
title_auth Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
title_new Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
title_sort clay-based pharmaceutical formulations and drug delivery systems
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (202 p.)
isbn 3-0365-0186-X
3-0365-0187-8
illustrated Not Illustrated
work_keys_str_mv AT viserascesar claybasedpharmaceuticalformulationsanddrugdeliverysystems
status_str n
ids_txt_mv (CKB)5400000000040756
(oapen)https://directory.doabooks.org/handle/20.500.12854/68311
(EXLCZ)995400000000040756
carrierType_str_mv cr
is_hierarchy_title Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
author2_original_writing_str_mv noLinkedField
_version_ 1796652254813487104
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03903nam-a2200925z--4500</leader><controlfield tag="001">993545151804498</controlfield><controlfield tag="005">20231214133245.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040756</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040756</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Viseras, César</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clay-Based Pharmaceutical Formulations and Drug Delivery Systems</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (202 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book includes recent advances in the use of clays in the design of medicinal products and medicinal devices. The pharmaceutical applications of nanoclays are far ranging, because of their distinct advantages: they are versatile (possess a wide range of mechanical, chemical and physical properties) and available at reasonable costs. Some special clays (mainly kaolinite, halloysite, montmorillonite, saponite, hectorite, palygorskite and sepiolite), as well as semi-synthetic (organoclays) or synthetic (double layer hydroxides) derivatives, are very useful materials for modulating drug delivery. In the last decade, several actives have been loaded onto nanoclays and similar inorganic excipients to increase solubility, improve stability, reduce toxicity, and enhance bioavailability, with a consequent increase in therapeutic response. Polymer/clay nanocomposites with synergic properties have been developed, showing improved mechanical properties with respect to the pristine polymer matrices and allowing modified release of loaded actives. Moreover, nanoclays have very recently demonstrated positive effects on the proliferation and migration of fibroblasts. The development of clay-based medicinal products and medicinal devices requires experience in the fields of both clay structure and properties and pharmaceutical technology design.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrochlorothiazide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cyclodextrins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sepiolite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoclay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dissolution rate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tablet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">electrospinning</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chitosan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chondroitin sulfate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">scaffolds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">montmorillonite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">halloysite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fibroblasts proliferation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycosaminoglycans</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial properties</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">palygorskite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spring water</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fibroblast</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biocompatibility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">wound healing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mesoporous clay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neusilin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aeroperl</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquisolid technique</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glyburide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dissolution improvement</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrotalcite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ketoprofen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hybrid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">photostability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel film</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioadhesion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heavy metal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hazardous element</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">element mobility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clay minerals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">palygorksite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proliferation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Franz cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioactive elements</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">praziquantel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">organic solvents</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro dissolution tests</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytotoxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">halloysite nanotube</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">osteosarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methotrexate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">surface modification</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0186-X</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0187-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Viseras, César</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:48:07 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337868060004498&amp;Force_direct=true</subfield><subfield code="Z">5337868060004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337868060004498</subfield></datafield></record></collection>